97016643
Sep 8, 2021
Pharmaceuticals for the treatment of agitation; pharmaceuticals for the treatment of agitation associated with neuropsychiatric conditions, neurodegenerative diseases, alcohol withdrawal, opioid use disorder, opioid withdrawal, substance abuse withdrawal, depression or symptoms associated with depression or other central nervous system disorders
Pharmaceuticals